US Broker Ratings

BGM Group Ltd. (BGM) Stock Analysis: Navigating a Challenging Market with Strategic Offerings in the Healthcare Sector

BGM Group Ltd. (BGM), a noteworthy player in the healthcare sector, operates within the dynamic landscape of drug manufacturing in China. Despite facing significant challenges, particularly in revenue growth, the..

PROCEPT BioRobotics (PRCT) Stock Analysis: Navigating a 68% Potential Upside in the Robotic Surgery Arena

For investors with an eye on the healthcare sector, particularly the burgeoning field of medical devices, PROCEPT BioRobotics Corporation (NASDAQ: PRCT) presents an intriguing opportunity. This San Jose-based company specializes..

Beam Therapeutics Inc. (BEAM)

⚠️ No article content returned.

..

Recursion Pharmaceuticals, Inc. (RXRX) Investor Outlook: Analyzing the 33.89% Potential Upside

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is making waves in the biotechnology sector with its innovative approach to drug discovery. As a clinical-stage company, Recursion is harnessing the power of technology..

AtriCure, Inc. (ATRC) Stock Analysis: Strong Buy Ratings and Impressive 32% Upside Potential

AtriCure, Inc. (NASDAQ: ATRC) is capturing significant attention in the healthcare sector, specifically within the medical instruments and supplies industry. With a robust market capitalization of $1.88 billion, AtriCure stands..

Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Analysis: Exploring a 40% Upside Potential in the Biopharma Sector

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA), a prominent player in the healthcare sector, is gaining attention for its innovative approach in addressing unmet medical needs. Based in the United Kingdom, this..

89bio, Inc. (ETNB) Stock Analysis: Uncovering a Remarkable 239.56% Potential Upside

For investors with an eye on the healthcare sector, particularly within the realm of biotechnology, 89bio, Inc. (NASDAQ: ETNB) presents a compelling case. This San Francisco-based clinical-stage biopharmaceutical company is..

PACS Group, Inc. (PACS)

⚠️ No article content returned.

..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Unpacking the 86.78% Potential Upside

For investors seeking opportunities in the medical devices sector, Tandem Diabetes Care, Inc. (NASDAQ: TNDM) presents an intriguing case. With a market capitalization of $818.27 million, this San Diego-based company..

Dyne Therapeutics (DYN) Stock Analysis: Significant Upside Potential with 171.95% Gain Forecast

For investors with an eye on the biotechnology sector, Dyne Therapeutics, Inc. (NASDAQ: DYN) represents a compelling opportunity, particularly given the substantial upside potential that analysts have forecasted. With a..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: A 22.53% Potential Upside Opportunity

Alignment Healthcare, Inc. (NASDAQ: ALHC) offers a compelling investment opportunity within the healthcare sector, specifically targeting the burgeoning market for senior care through its innovative Medicare Advantage plans. With a..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Navigating Through Growth Challenges in the Healthcare Sector

Pediatrix Medical Group, Inc. (NYSE: MD), a key player in the U.S. medical care facilities industry, has been on investors’ radars due to its specialized focus on neonatal and maternal-fetal..

Clover Health Investments, Corp (CLOV): Unpacking the 38% Potential Upside in Healthcare Plans

Clover Health Investments, Corp (NASDAQ: CLOV) is making waves in the healthcare sector, particularly within the healthcare plans industry. With a current market capitalization of $1.36 billion, this Delaware-based company..

Adaptive Biotechnologies (ADPT) Stock Analysis: A 10.5% Upside in the Biotech Sector

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) presents an intriguing opportunity for investors seeking exposure in the dynamic biotechnology sector. With a market capitalization of $1.93 billion, this Seattle-based company is carving..

Privia Health Group, Inc. (PRVA) Stock Analysis: Navigating a 40% Upside Potential

Privia Health Group, Inc. (NASDAQ: PRVA) stands out in the healthcare sector as a dynamic player within the health information services industry. With a market capitalization of $2.63 billion, Privia..

Certara, Inc. (CERT) Stock Analysis: Unveiling a 30% Potential Upside in the Healthcare Sector

Certara, Inc. (NASDAQ: CERT), a prominent player in the healthcare sector specializing in health information services, is capturing the attention of investors with its significant growth potential. With a market..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Strong Buy Ratings and 29% Upside Potential

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX), a key player in the healthcare sector, is capturing attention for its promising growth potential and favorable analyst ratings. Based in Bridgewater, New Jersey, Amneal..

Janux Therapeutics, Inc. (JANX) Stock Analysis: A Biotech with a Potential Upside of 258% – Is It Worth the Risk?

Janux Therapeutics, Inc. (JANX), a burgeoning name in the biotechnology sector, is currently capturing the attention of individual investors with its promising advancements in cancer immunotherapy. The company, headquartered in..

Progyny, Inc. (PGNY) Stock Analysis: Exploring a 22% Upside Potential in the Booming Healthcare Sector

Progyny, Inc. (NASDAQ: PGNY), a prominent player in the healthcare sector, is capturing investor attention with a compelling blend of market potential and financial resilience. Headquartered in New York, Progyny..

Phreesia, Inc. (PHR) Stock Analysis: A Promising Healthcare Tech Play with 45.7% Revenue Growth

Phreesia, Inc. (PHR), a key player in the healthcare technology sector, is making waves with its impressive revenue growth of 45.7%. As a company specializing in SaaS-based solutions for healthcare..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds